Literature DB >> 21478594

Alveolar soft-part sarcoma of the orbit.

Anna M Rose1, Joy Kabiru, Geoffrey E Rose.   

Abstract

Alveolar soft-part sarcoma (ASPS) is a rare soft tissue tumour of uncertain cellular origin. It accounts for only 1% of all sarcomas, which themselves represent only a small proportion of human tumours. ASPS can arise in any soft tissue of the body, but there is an unexplained predilection for the right side. The most common site for paediatric ASPS is in the head and neck region, although involvement of the orbit is rare, with fewer than 30 reported cases. A case of a 5-year-old Kenyan boy with left-sided orbital ASPS is reported and the difficulties of diagnosing rare tumours are discussed.

Entities:  

Mesh:

Year:  2011        PMID: 21478594     DOI: 10.4103/0189-6725.78936

Source DB:  PubMed          Journal:  Afr J Paediatr Surg        ISSN: 0974-5998


  5 in total

Review 1.  Rare Diseases of the Orbit.

Authors:  Ulrich Kisser; Jens Heichel; Alexander Glien
Journal:  Laryngorhinootologie       Date:  2021-04-30       Impact factor: 1.057

2.  Adult alveolar soft part sarcoma of the head and neck: a report of two cases and literature review.

Authors:  Brandon T Mullins; Trevor Hackman
Journal:  Case Rep Oncol Med       Date:  2014-12-23

3.  Orbital alveolar soft part sarcoma: A report of 8 cases and review of the literature.

Authors:  Yan Hei; Li Kang; Xinji Yang; Yi Wang; Xiaozhong Lu; Yueyue Li; Wei Zhang; Lihua Xiao
Journal:  Oncol Lett       Date:  2017-10-30       Impact factor: 2.967

4.  Alveolar soft part sarcoma of the superior rectus muscle: Case report and review of literature.

Authors:  Seyed Mohsen Rafizadeh; Kasra Cheraqpour; Fahimeh Asadi Amoli; Ali A Haydar
Journal:  Am J Ophthalmol Case Rep       Date:  2022-07-03

Review 5.  Paediatric orbital alveolar soft part sarcoma recurrence during long-term follow-up: a report of 3 cases and a review of the literature.

Authors:  Yujiao Wang; Baixue Du; Mei Yang; Weimin He
Journal:  BMC Ophthalmol       Date:  2020-02-21       Impact factor: 2.209

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.